Invention Grant
- Patent Title: Marker for determination of sensitivity to anti-cancer agent
- Patent Title (中): 测定抗癌药敏感性的标记
-
Application No.: US12865725Application Date: 2009-01-30
-
Publication No.: US08945929B2Publication Date: 2015-02-03
- Inventor: Yusuke Tanigawara , Mitsuhiro Watanabe , Eri Arita , Akito Nishimuta , Yasuko Yamayoshi , Takeshi Matsuzaki , Shinji Sugimoto
- Applicant: Yusuke Tanigawara , Mitsuhiro Watanabe , Eri Arita , Akito Nishimuta , Yasuko Yamayoshi , Takeshi Matsuzaki , Shinji Sugimoto
- Applicant Address: JP Tokyo JP Tokyo
- Assignee: Keio University,Kabushiki Kaisha Yakult Honsha
- Current Assignee: Keio University,Kabushiki Kaisha Yakult Honsha
- Current Assignee Address: JP Tokyo JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2008-021123 20080131
- International Application: PCT/JP2009/000358 WO 20090130
- International Announcement: WO2009/096189 WO 20090806
- Main IPC: G01N33/48
- IPC: G01N33/48 ; G01N33/53 ; A61K31/4745 ; A61K45/06 ; G01N33/50 ; G01N33/68
Abstract:
Provided are a marker for determining sensitivity to an anticancer agent capable of distinguishing a therapeutic response of an individual patient and a novel means for a cancer therapy using the marker. The marker for determining sensitivity to an anticancer agent contains a substance in a metabolic pathway in which L-phenylalanine and/or N,N-dimethyl glycine are/is involved.
Public/Granted literature
- US20110003842A1 MARKER FOR DETERMINATION OF SENSITIVITY TO ANTI-CANCER AGENT Public/Granted day:2011-01-06
Information query
